New drugs approved for use in Scottish NHS

The Scottish Medicines Consortium (SMC) has accepted the following new drugs for use within NHS Scotland:

  • Rotigotine (Neupro) for the symptomatic treatment of moderate to severe idiopathic restless legs syndrome in adults.
  • Etravirine (Intelence) for use in combination with a boosted protease inhibitor and other antiretroviral agents, to treat HIV-1 infection in antiretroviral-experienced adults.
  • Histrelin (Vantas) subcutaneous implant for restricted use in the palliative treatment of advanced prostate cancer.
  • Calcipotriol and betamethasone dipropionate scalp gel (Xamiol) for the topical treatment of scalp psoriasis.
  • Peginterferon alfa-2a (Pegasys) for use in combination with ribavirin to treat chronic hepatitis C in adults.

The SMC rejected degarelix (Firmagon) for the treatment of men with advanced hormone-dependent prostate cancer.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases